Abstract
Numerous clinical proteomics studies are focused on the development of biomarkers to improve either diagnostics for early disease detection or the monitoring of the response to the treatment. Although, a wealth of biomarker candidates are available, their evaluation and validation in a true clinical setup remains challenging. In biomarkers evaluation studies, a panel of proteins of interest are systematically analyzed in a large cohort of samples. However, in spite of the latest progresses in mass spectrometry, the consistent detection of pertinent proteins in high complex biological samples is still a challenging task. Thus, targeted LC-MS/MS methods are better suited for the systematic analysis of biomarkers rather than shotgun approaches. This chapter describes the workflow used to perform targeted quantitative analyses of proteins in urinary samples. The peptides, as surrogates of the protein of interest, are commonly measured using a triple quadrupole mass spectrometers operated in selected reaction monitoring (SRM) mode. More recently, the advances in targeted LC-MS/MS analysis based on parallel reaction monitoring (PRM) performed on a quadrupole-orbitrap instrument have allowed to increase the specificity and selectivity of the measurements.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsSpringer Nature is developing a new tool to find and evaluate Protocols. Learn more
References
Decramer S, Gonzalez de Peredo A, Breuil B et al (2008) Urine in clinical proteomics. Mol Cell Proteomics 7:1850–1862
Picotti P, Bodenmiller B, Mueller LN et al (2009) Full dynamic range proteome analysis of S. cerevisiae by targeted proteomics. Cell 138:795–806
Kiyonami R, Domon B (2010) Selected reaction monitoring applied to quantitative proteomics. In: Cutillas P, Timms J (eds) Methods Mol Biol. LC-MS/MS in proteomics. Springer, Hatfield
EuroKUP Standard Protocol for Urine Collection. www.eurokup.org/node/127
Mischak H, Kolch W, Aivaliotis M et al (2010) Comprehensive human urine standards for comparability and standardization in clinical proteome analysis. Proteomics Clin Appl 4:464–478
Court M, Selevsek N, Matondo M et al (2011) Toward a standardized urine proteome analysis methodology. Proteomics 11:1160–1171
Chen YT, Chen HW, Domanski D et al (2012) Multiplexed quantification of 63 proteins in human urine by multiple reaction monitoring-based mass spectrometry for discovery of potential bladder cancer biomarkers. J Proteomics 75:3529–3545
Selevsek N, Matondo M, Sanchez Carbayo M et al (2011) Systematic quantification of peptides/proteins in urine using selected reaction monitoring. Proteomics 11:1135–1147
Peterson AC, Russell JD, Bailey DJ et al (2012) Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol Cell Proteomics 11:1475–1488
Gallien S, Duriez E, Crone C et al (2012) Targeted proteomic quantification on quadrupole-orbitrap mass spectrometer. Mol Cell Proteomics 11:1709–1723
Gallien S, Peterman S, Kiyonami R et al (2012) Highly multiplexed targeted proteomics using precise control of peptide retention time. Proteomics 12:1122–1133
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Deutsch EW, Lam H, Aebersold R (2008) PeptideAtlas: a resource for target selection for emerging targeted proteomics workflows. EMBO Rep 9:429–434
Craig R, Cortens JP, Beavis RC (2004) Open source system for analyzing, validating, and storing protein identification data. J Proteome Res 3:1234–1242
Picotti P, Lam H, Campbell D et al (2008) A database of mass spectrometric assays for the yeast proteome. Nat Methods 5:913–914
Stahl-Zeng J, Lange V, Ossola R et al (2007) High sensitivity detection of plasma proteins by multiple reaction monitoring of N-glycosites. Mol Cell Proteomics 6:1809–1817
Prakash A, Kiyonami R, Schoen A, et al. (2009) Integrated workflow to design methods and analyze data in large-to-extremely-large scale SRM experiments. Paper presented at the the 57th American Society for Mass Spectrometry conference, Philadelphia, Pennsylvania, May 31–June 4 2009
Gallien S, Duriez E, Domon B (2011) Selected reaction monitoring applied to proteomics. J Mass Spectrom 46:298–312
Lange V, Picotti P, Domon B et al (2008) Selected reaction monitoring for quantitative proteomics: a tutorial. Mol Syst Biol 4:222
Kiyonami R, Schoen A, Prakash A et al (2011) Increased selectivity, analytical precision, and throughput in targeted proteomics. Mol Cell Proteomics 10(M110):002931
US Department of Health and Human Services F, Center for Drug Evaluation and Research (2001) Guidance for industry: bioanalytical method validation. US Department of Health and Human Services F, Center for Drug Evaluation and Research, Rockville, MD
Acknowledgements
Nina Khristenko thanks Luxembourg FNR (AFR grant 1364383). Bruno Domon acknowledges Luxembourg FNR (PEARL grant). We are grateful to Elodie Duriez, Sebastien Gallien, Cérdic Mesmin, Cristina Maximo, and Stéphane Trevisiol for helpful discussion and comments.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Science+Business Media New York
About this protocol
Cite this protocol
Khristenko, N., Domon, B. (2015). Quantification of Proteins in Urine Samples Using Targeted Mass Spectrometry Methods. In: Vlahou, A., Makridakis, M. (eds) Clinical Proteomics. Methods in Molecular Biology, vol 1243. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-1872-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4939-1872-0_12
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-1871-3
Online ISBN: 978-1-4939-1872-0
eBook Packages: Springer Protocols